Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cascade of care during the first 36 months of the treatment as prevention for hepatitis C (TraP HepC) programme in Iceland: a population-based study.
Olafsson S, Fridriksdottir RH, Love TJ, Tyrfingsson T, Runarsdottir V, Hansdottir I, Bergmann OM, Björnsson ES, Johannsson B, Sigurdardottir B, Löve A, Baldvinsdottir GE, Hernandez UB, Gudnason T, Heimisdottir M, Hellard M, Gottfredsson M. Olafsson S, et al. Among authors: love tj, love a. Lancet Gastroenterol Hepatol. 2021 Aug;6(8):628-637. doi: 10.1016/S2468-1253(21)00137-0. Epub 2021 Jun 23. Lancet Gastroenterol Hepatol. 2021. PMID: 34171267
Treatment as Prevention for Hepatitis C (TraP Hep C) - a nationwide elimination programme in Iceland using direct-acting antiviral agents.
Olafsson S, Tyrfingsson T, Runarsdottir V, Bergmann OM, Hansdottir I, Björnsson ES, Johannsson B, Sigurdardottir B, Fridriksdottir RH, Löve A, Hellard M, Löve TJ, Gudnason T, Heimisdottir M, Gottfredsson M. Olafsson S, et al. Among authors: love tj, love a. J Intern Med. 2018 May;283(5):500-507. doi: 10.1111/joim.12740. Epub 2018 Mar 7. J Intern Med. 2018. PMID: 29512219 Free article.
High Rate of Hepatitis C Virus Reinfection Among Recently Injecting Drug Users: Results From the TraP Hep C Program-A Prospective Nationwide, Population-Based Study.
Johannesson JM, Fridriksdottir RH, Löve TJ, Runarsdottir V, Hansdóttir I, Löve A, Thordardottir M, Hernandez UB, Olafsson S, Gottfredsson M; Treatment as Prevention for Hepatitis C (TraP Hep C) group. Johannesson JM, et al. Among authors: love tj, love a. Clin Infect Dis. 2022 Nov 14;75(10):1732-1739. doi: 10.1093/cid/ciac272. Clin Infect Dis. 2022. PMID: 35438144 Free PMC article.
Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies.
Rögnvaldsson S, Love TJ, Thorsteinsdottir S, Reed ER, Óskarsson JÞ, Pétursdóttir Í, Sigurðardóttir GÁ, Viðarsson B, Önundarson PT, Agnarsson BA, Sigurðardóttir M, Þorsteinsdóttir I, Ólafsson Í, Þórðardóttir ÁR, Eyþórsson E, Jónsson Á, Björnsson AS, Gunnarsson GÞ, Pálsson R, Indriðason ÓS, Gíslason GK, Ólafsson A, Hákonardóttir GK, Brinkhuis M, Halldórsdóttir SL, Ásgeirsdóttir TL, Steingrímsdóttir H, Danielsen R, Dröfn Wessman I, Kampanis P, Hultcrantz M, Durie BGM, Harding S, Landgren O, Kristinsson SY. Rögnvaldsson S, et al. Among authors: love tj. Blood Cancer J. 2021 May 17;11(5):94. doi: 10.1038/s41408-021-00480-w. Blood Cancer J. 2021. PMID: 34001889 Free PMC article. Clinical Trial.
Illness severity and risk of mental morbidities among patients recovering from COVID-19: a cross-sectional study in the Icelandic population.
Saevarsdóttir KS, Hilmarsdóttir HÝ, Magnúsdóttir I, Hauksdóttir A, Thordardottir EB, Gudjónsdóttir ÁB, Tomasson G, Rúnarsdóttir H, Jónsdóttir HL, Gudmundsdóttir B, Pétursdóttir G, Petersen PH, Kristinsson SY, Love TJ, Hansdóttir S, Hardardóttir H, Gudmundsson G, Eythorsson E, Gudmundsdóttir DG, Sigbjörnsdóttir H, Haraldsdóttir S, Möller AD, Palsson R, Jakobsdóttir J, Aspelund T, Valdimarsdottir U. Saevarsdóttir KS, et al. Among authors: love tj. BMJ Open. 2021 Jul 23;11(7):e049967. doi: 10.1136/bmjopen-2021-049967. BMJ Open. 2021. PMID: 34301663 Free PMC article.
Patients with psoriatic arthritis who are not eligible for randomised controlled trials for TNF inhibitors have treatment response and drug survival similar to those who are eligible.
Palsson O, Love TJ, Gunnarsdottir AI, Gunnarsson PS, Runarsdottir EE, Krogh NS, Gudbjornsson B. Palsson O, et al. Among authors: love tj. RMD Open. 2019 Jul 16;5(2):e000984. doi: 10.1136/rmdopen-2019-000984. eCollection 2019. RMD Open. 2019. PMID: 31413869 Free PMC article.
89 results